Zacks Research Weighs in on DocuSign, Inc.’s Q1 2025 Earnings (NASDAQ:DOCU)

DocuSign, Inc. (NASDAQ:DOCU) – Equities research analysts at Zacks Research boosted their Q1 2025 EPS estimates for DocuSign in a report released on Wednesday, April 24th. Zacks Research analyst R. Department now anticipates that the company will earn $0.22 per share for the quarter, up from their previous forecast of $0.19. The consensus estimate for DocuSign’s current full-year earnings is $0.86 per share. Zacks Research also issued estimates for DocuSign’s Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.18 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.76 EPS, Q1 2026 earnings at $0.23 EPS, Q2 2026 earnings at $0.16 EPS, Q3 2026 earnings at $0.20 EPS, Q4 2026 earnings at $0.16 EPS, FY2026 earnings at $0.77 EPS and FY2027 earnings at $0.75 EPS.

DocuSign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, March 7th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The firm had revenue of $712.39 million for the quarter, compared to analyst estimates of $698.05 million.

Several other analysts also recently commented on DOCU. JMP Securities reiterated a “market outperform” rating and issued a $84.00 price target on shares of DocuSign in a research report on Friday, April 12th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday, April 12th. UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and lifted their target price for the company from $48.00 to $62.00 in a research note on Friday, April 12th. Royal Bank of Canada restated a “sector perform” rating and set a $59.00 price target on shares of DocuSign in a research note on Friday, April 12th. Finally, Wells Fargo & Company lowered their price objective on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research report on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $60.25.

DocuSign Stock Down 0.3 %

DOCU opened at $57.20 on Friday. DocuSign has a 52 week low of $38.11 and a 52 week high of $64.76. The business’s 50 day moving average is $56.49 and its two-hundred day moving average is $52.65. The firm has a market cap of $11.75 billion, a price-to-earnings ratio of 158.89, a price-to-earnings-growth ratio of 5.01 and a beta of 0.89.

Institutional Investors Weigh In On DocuSign

A number of institutional investors and hedge funds have recently bought and sold shares of DOCU. Capital Analysts LLC raised its holdings in DocuSign by 781.7% in the 4th quarter. Capital Analysts LLC now owns 529 shares of the company’s stock valued at $31,000 after acquiring an additional 469 shares during the last quarter. BluePath Capital Management LLC purchased a new position in DocuSign during the third quarter worth about $32,000. McGlone Suttner Wealth Management Inc. acquired a new stake in DocuSign in the 4th quarter worth about $32,000. Performa Ltd US LLC grew its holdings in DocuSign by 50.0% in the 3rd quarter. Performa Ltd US LLC now owns 825 shares of the company’s stock valued at $35,000 after buying an additional 275 shares during the period. Finally, Register Financial Advisors LLC acquired a new position in shares of DocuSign during the 1st quarter valued at about $37,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insider Activity

In related news, CEO Allan C. Thygesen sold 7,680 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the sale, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the sale, the chief executive officer now directly owns 111,767 shares in the company, valued at approximately $6,847,964.09. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Teresa Briggs sold 499 shares of the business’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $52.99, for a total value of $26,442.01. Following the sale, the director now directly owns 6,169 shares in the company, valued at approximately $326,895.31. The disclosure for this sale can be found here. Insiders sold 54,871 shares of company stock worth $3,176,199 in the last 90 days. 17.80% of the stock is currently owned by corporate insiders.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.